Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17(2):107–15.
Article
CAS
PubMed
Google Scholar
Adinolfi LE, Nevola R, Lus G, Restivo L, Guerrera B, Romano C, et al. Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. World J Gastroenterol. 2015;21(8):2269–80.
Article
PubMed
PubMed Central
Google Scholar
Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. The Lancet. 2001;358(9275):38–9.
Article
CAS
Google Scholar
Mazzaro C, Quartuccio L, Adinolfi LE, Roccatello D, Pozzato G, Nevola R, et al. A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy. Viruses. 2021;13:11.
Article
Google Scholar
Carithers RL Jr, Sugano D, Bayliss M. Health assessment for chronic HCV infection: results of quality of life. Dig Dis Sci. 1996;41(12 Suppl):75s–80s.
Article
PubMed
Google Scholar
Tully DC, Hjerrild S, Leutscher PD, Renvillard SG, Ogilvie CB, Bean DJ, et al. Deep sequencing of hepatitis C virus reveals genetic compartmentalization in cerebrospinal fluid from cognitively impaired patients. Liver Int. 2016;36(10):1418–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet. 2001;358(9275):38–9.
Article
CAS
PubMed
Google Scholar
Battaglia S, Serio G, Scarpazza C, D’Ausilio A, Borgomaneri S. Frozen in (e)motion: How reactive motor inhibition is influenced by the emotional content of stimuli in healthy and psychiatric populations. Behav Res Ther. 2021;146: 103963.
Article
PubMed
Google Scholar
Battaglia S, Fabius JH, Moravkova K, Fracasso A, Borgomaneri S. The neurobiological correlates of gaze perception in healthy individuals and neurologic patients. Biomedicines. 2022;10(3):627.
Article
PubMed
PubMed Central
Google Scholar
Battaglia S, Harrison BJ, Fullana MA. Does the human ventromedial prefrontal cortex support fear learning, fear extinction or both? A commentary on subregional contributions. Mol Psychiatry. 2022;27(2):784–6.
Article
PubMed
Google Scholar
Battaglia S, Thayer JF. Functional interplay between central and autonomic nervous systems in human fear conditioning. Trends Neurosci. 2022;45(7):504–6.
Article
CAS
PubMed
Google Scholar
Tanaka M, Vécsei L. Monitoring the kynurenine system: Concentrations, ratios or what else? Adv Clin Exp Med. 2021;30(8):775–8.
Article
PubMed
Google Scholar
Avan R, Sahebnasagh A, Hashemi J, Monajati M, Faramarzi F, Henney NC, et al. Update on statin treatment in patients with neuropsychiatric disorders. Life. 2021;11(12):1365.
Article
CAS
PubMed
PubMed Central
Google Scholar
Komatsu H, Watanabe E, Fukuchi M. Psychiatric neural networks and precision therapeutics by machine learning. Biomedicines. 2021;9(4):403.
Article
PubMed
PubMed Central
Google Scholar
Spekker E, Tanaka M, Szabó Á, Vécsei L. Neurogenic inflammation: the participant in migraine and recent advancements in translational research. Biomedicines. 2022;10(1):76.
Article
CAS
Google Scholar
Tanaka M, Vécsei L. Editorial of Special Issue “Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry”. Biomedicines. 2021;9(5):517.
Tanaka M, Tóth F, Polyák H, Szabó Á, Mándi Y, Vécsei L. Immune influencers in action: metabolites and enzymes of the Tryptophan-Kynurenine Metabolic Pathway. Biomedicines. 2021;9(7):734.
Article
CAS
PubMed
PubMed Central
Google Scholar
Udina M, Castellví P, Moreno-España J, Navinés R, Valdés M, Forns X, et al. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry. 2012;73(8):1128–38.
Article
CAS
PubMed
Google Scholar
Evon DM, Esserman DE, Howell MA, Ruffin RA. Pegylated interferon pharmacokinetics and self-reported depressive symptoms during antiviral treatment for chronic hepatitis C. Pharmacopsychiatry. 2014;47(6):195–201.
Article
CAS
PubMed
PubMed Central
Google Scholar
AASLD/DSA HCV guidance panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62(3):932–54.
Article
Google Scholar
Sahar M, Hassany AMD, Hossam K, Gellan KA, Haidi KAR, Ehab FM. Prevalence and Risk Factors of Depression and Anxiety in Hepatitis C Patients Receiving Pegylated Interferon Alpha (IFN-a). Int J Curr Microbiol Appl Sci. 2017;6(10):484–93.
Article
Google Scholar
Hassaan SH, Darwish AM, Khalifa H, Ramadan HKA, Hassany SM, Ahmed GK, et al. Assessment of cognitive functions and psychiatric symptoms in hepatitis C patients receiving pegylated interferon alpha and ribavirin: A prospective cohort study. Int J Psychiatry Med. 2019;54(6):424–40.
Article
PubMed
Google Scholar
Adinolfi LE, Petta S, Fracanzani AL, Coppola C, Narciso V, Nevola R, et al. Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: a prospective multicentre study. Atherosclerosis. 2020;296:40–7.
Article
CAS
PubMed
Google Scholar
Shahid I, Ibrahim MM. All oral interferon-free direct-acting antivirals as combination therapies to cure hepatitis C. Curr Mol Med. 2018;18(7):409–35.
Article
CAS
PubMed
Google Scholar
Sulkowski MS, Vargas HE, Di Bisceglie AM, Kuo A, Reddy KR, Lim JK, et al. Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection. Gastroenterology. 2016;150(2):419–29.
Article
PubMed
Google Scholar
Younossi ZM, Stepanova M, Marcellin P, Afdhal N, Kowdley KV, Zeuzem S, et al. Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials. Hepatology. 2015;61(6):1798–808.
Article
CAS
PubMed
Google Scholar
Younossi ZM, Stepanova M, Jacobson IM, Asselah T, Gane EJ, Lawitz E, et al. Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3. Aliment Pharmacol Ther. 2018;47(2):259–67.
Article
CAS
PubMed
Google Scholar
Gragnani L, Lorini S, Martini L, Stasi C, Visentini M, Petraccia L, et al. Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis. Clin Rheumatol. 2022;41(1):147–57.
Article
PubMed
Google Scholar
Marcellin P, Chousterman M, Fontanges T, Ouzan D, Rotily M, Varastet M, et al. Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study. Liver Int. 2011;31(4):516–24.
Article
CAS
PubMed
Google Scholar
Rowan PJ, Bhulani N. Psychosocial assessment and monitoring in the new era of non-interferon-alpha hepatitis C virus treatments. World J Hepatol. 2015;7(19):2209.
Article
PubMed
PubMed Central
Google Scholar
Ho SB, Monto A, Peyton A, Kaplan DE, Byrne S, Moon S, et al. Efficacy of sofosbuvir plus ribavirin in veterans with hepatitis C virus genotype 2 infection, compensated cirrhosis, and multiple comorbidities. Clin Gastroenterol Hepatol. 2017;15(2):282–8.
Article
CAS
PubMed
Google Scholar
Ioannou GN, Beste LA, Chang MF, Green PK, Lowy E, Tsui JI, et al. Effectiveness of sofosbuvir, ledipasvir/sofosbuvir, or paritaprevir/ritonavir/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the veterans affairs National Health Care System. Gastroenterology. 2016;151(3):457-71.e5.
Article
CAS
PubMed
Google Scholar
Rowan PJ. What psychiatric screening and monitoring might be needed with the new generation of hepatitis C treatments? World J Virol. 2015;4(1):13–6.
Article
PubMed
PubMed Central
Google Scholar
Sockalingam S, Sheehan K, Feld JJ, Shah H. Psychiatric care during hepatitis C treatment: the changing role of psychiatrists in the era of direct-acting antivirals. Am J Psychiatry. 2015;172(6):512–6.
Article
PubMed
Google Scholar
Anwar W, Sarwar M, Hussain AB, Tariq WU, Saif M. Significance of occult HBV infection in patients with chronic hepatitis C. J Coll Physicians Surg Pak. 2006;16(3):192–5.
PubMed
Google Scholar
Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371(9615):838–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.
Article
PubMed
Google Scholar
Foster GR, Afdhal N, Roberts SK, Bräu N, Gane EJ, Pianko S, et al. Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection. N Engl J Med. 2015;373(27):2608–17.
Article
CAS
PubMed
Google Scholar
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–9.
Article
CAS
PubMed
Google Scholar
Ahmed OA, Safwat E, Khalifa MO, Elshafie AI, Fouad MHA, Salama MM, et al. Sofosbuvir Plus Daclatasvir in treatment of chronic hepatitis C Genotype 4 infection in a cohort of Egyptian patients: an experiment the size of Egyptian village. Int J Hepatol. 2018;2018:9616234.
Article
PubMed
PubMed Central
Google Scholar
Poordad F, Schiff ER, Vierling JM, Landis C, Fontana RJ, Yang R, et al. Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence. Hepatology. 2016;63(5):1493–505.
Article
CAS
PubMed
Google Scholar
EASL eAftSotL. EASL recommendations on treatment of Hepatitis C 2016. J Hepatol. 2017;66(1):153–94.
Yoshida EM, Sulkowski MS, Gane EJ, Herring RW Jr, Ratziu V, Ding X, et al. Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus. Hepatology. 2015;61(1):41–5.
Article
CAS
PubMed
Google Scholar
Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91.
Article
PubMed
Google Scholar
Fahmy S, El-Sherbini AF. Determining simple parameters for social classifications for health research. Bull High Inst Public Health. 1983;13:95–108.
Google Scholar
Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278–96.
Article
CAS
PubMed
Google Scholar
Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:55.
Article
Google Scholar
Evans DA, Beckett LA, Albert MS, Hebert LE, Scherr PA, Funkenstein HH, et al. Level of education and change in cognitive function in a community population of older persons. Ann Epidemiol. 1993;3(1):71–7.
Article
PubMed
Google Scholar
Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology. 2002;35(2):440–6.
Article
PubMed
Google Scholar
Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34(5):768–73.
Article
CAS
PubMed
Google Scholar
Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc. 2003;9(6):847–54.
Article
PubMed
Google Scholar
Danilescu CM, Sandulescu DL, Pirlog MC, Streba CT, Rogoveanu I. Depressive and anxious symptoms in hepatitis c virus infected patients receiving DAA-Based Therapy. Diagnostics (Basel). 2021;11:12.
Google Scholar
Kesen O, Kani HT, Yanartaş Ö, Aykut UE, Gök B, Gündüz F, et al. Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents. Turk J Gastroenterol. 2019;30(9):801–6.
Article
PubMed
PubMed Central
Google Scholar
Ferenci P, Bernstein D, Lalezari J, Cohen D, Luo Y, Cooper C, et al. ABT-450/rombitasvir and dasabuvir with or without ribavirin for HCV. N Engl J Med. 2014;370(21):1983–92.
Article
PubMed
Google Scholar
Kaur H, Dhiman RK, Kulkarni AV, Premkumar M, Singh V, Duseja AK, et al. Improvement of chronic HCV infection-related depression, anxiety, and neurocognitive performance in persons achieving SVR-12: A real-world cohort study. J Viral Hepat. 2022;29(5):395–406.
Article
CAS
PubMed
Google Scholar
Dieperink E, Ho SB, Thuras P, Willenbring ML. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics. 2003;44(2):104–12.
Article
CAS
PubMed
Google Scholar
Carta MG, Hardoy MC, Garofalo A, Pisano E, Nonnoi V, Intilla G, et al. Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy. Clin Pract Epidemiol Ment Health. 2007;3:22.
Article
PubMed
PubMed Central
Google Scholar
Carta MG, Angst J, Moro MF, Mura G, Hardoy MC, Balestrieri C, et al. Association of chronic hepatitis C with recurrent brief depression. J Affect Disord. 2012;141(2–3):361–6.
Article
PubMed
Google Scholar
Nardelli S, Riggio O, Rosati D, Gioia S, Farcomeni A, Ridola L. Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms. World J Gastroenterol. 2019;25(48):6928–38.
Article
PubMed
PubMed Central
Google Scholar
Gascon MRP, Benute GRG, Macedo EC, CapitÃo CG, Vidal JE, Smid J, et al. Cognitive assessment in patients with Hepatitis C submitted to treatment with Sofosbuvir and Simeprevir or Daclatasvir. Arq Neuropsiquiatr. 2020;78(6):342–8.
Article
PubMed
Google Scholar
Kleefeld F, Heller S, Ingiliz P, Jessen H, Petersen A, Kopp U, et al. Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV/HIV coinfected patients: effect on cognitive function, fatigue, and mental health. J Neurovirol. 2018;24(5):557–69.
Article
CAS
PubMed
Google Scholar
Forton DM, Allsop JM, Cox IJ, Hamilton G, Wesnes K, Thomas HC, et al. A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS. 2005;19(Suppl 3):S53-63.
Article
PubMed
Google Scholar
Weissenborn K, Tryc AB, Heeren M, Worthmann H, Pflugrad H, Berding G, et al. Hepatitis C virus infection and the brain. Metab Brain Dis. 2009;24(1):197–210.
Article
PubMed
Google Scholar
Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol. 2004;78(10):5170–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002;35(2):433–9.
Article
PubMed
Google Scholar
Thein HH, Maruff P, Krahn MD, Kaldor JM, Koorey DJ, Brew BJ, et al. Improved cognitive function as a consequence of hepatitis C virus treatment. HIV Med. 2007;8(8):520–8.
Article
CAS
PubMed
Google Scholar
Laskus T, Radkowski M, Bednarska A, Wilkinson J, Adair D, Nowicki M, et al. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol. 2002;76(19):10064–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Modabbernia A, Ashrafi M, Keyvani H, Taslimi S, Poorkaveh A, Merat S, et al. Brain-derived neurotrophic factor predicts physical health in untreated patients with hepatitis C. Biol Psychiatry. 2011;70(5):e31–2.
Article
CAS
PubMed
Google Scholar
Chen R, Liang FX, Moriya J, Yamakawa J, Sumino H, Kanda T, et al. Chronic fatigue syndrome and the central nervous system. J Int Med Res. 2008;36(5):867–74.
Article
CAS
PubMed
Google Scholar
Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev. 2004;45(2):104–14.
Article
CAS
PubMed
Google Scholar
Borgomaneri S, Battaglia S, Sciamanna G, Tortora F, Laricchiuta D. Memories are not written in stone: Re-writing fear memories by means of non-invasive brain stimulation and optogenetic manipulations. Neurosci Biobehav Rev. 2021;127:334–52.
Article
PubMed
Google Scholar
Borgomaneri S, Battaglia S, Avenanti A, Pellegrino G. Don’t Hurt Me No More: State-dependent Transcranial Magnetic Stimulation for the treatment of specific phobia. J Affect Disord. 2021;286:78–9.
Article
PubMed
Google Scholar
Tortella G, Selingardi PM, Moreno ML, Veronezi BP, Brunoni AR. Does non-invasive brain stimulation improve cognition in major depressive disorder? A systematic review. CNS Neurol Disord Drug Targets. 2014;13(10):1759–69.
Article
PubMed
Google Scholar
Mutz J, Edgcumbe DR, Brunoni AR, Fu CHY. Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: A systematic review and meta-analysis of randomised sham-controlled trials. Neurosci Biobehav Rev. 2018;92:291–303.
Article
PubMed
Google Scholar